News & Information

At Memorial Sloan Kettering, our leading edge research is constantly advancing what we know about cancer and new discoveries are improving care for patients here, and all over the world. In News and Information, you will find information about our groundbreaking work and the dedicated professionals who make it all happen.

For Journalists

Connect with us to reach MSK experts for media inquiries and for story ideas.

Learn more

Richard Nixon with Benno Schmidt (right) and Mr. Schmidt’s wife, Nancy, at the signing of the National Cancer Act
For more than 137 years, MSK has made historic contributions driving discovery and improving patient care. Take a look back at the progress we've made since the signing of the National Cancer Act in 1971.
In the News
View all articles
News Releases
Luis Alberto Diaz, Jr., MD and Andrea Cercek, MD
Breakthrough findings were presented at the 2022 ASCO Annual Meeting and published in The New England Journal of Medicine today by researchers at Memorial Sloan Kettering Cancer Center (MSK) confirming a clinical complete response in all 14 patients who received the immunotherapy treatment dostarlimab as a first-line treatment for mismatch repair-deficient (MMRd) locally advanced rectal cancer. This new approach of “immunoablative” therapy uses immunotherapy to replace surgery, chemotherapy and radiation to remove cancer.
View all news releases

Media Coverage

 

A clinical trial run by Amgen that combined its KRAS-targeting cancer drug called Lumakras with other immunotherapies caused serious liver side effects — forcing lung cancer patients to abandon treatment and leading to substantially lower tumor response rates .MSK’s Bob Li is featured.
Monday, August 8, 2022
 
U.S. News & World Report analyzed 1,586 hospitals and ranked the top 50 for gastroenterology and GI surgery. MSK is mentioned. 
Wednesday, July 27, 2022
 
MSK has been recognized as the number two hospital in the nation for cancer care by U.S. News & World Report in its annual Best Hospitals listing. This marks the 33rd year in a row that MSK has ranked among the top two cancer hospitals in the country, a tribute to our exceptional staff.
 
Tuesday, July 26, 2022
 

View all media coverage
News from the Lab
MSK News
Lymphoma patient Symantha Wilson
Symantha Wilson was crushed when chemotherapy quit fighting her lymphoma — and thrilled when immuno¬therapy beat back the cancer. But why doesn’t immunotherapy help more people? MSK researchers are finding answers.
Bridget Anderson
To help Bridget Anderson overcome leukemia, MSK doctors called upon her own microbiome, the vast ecosystem of microorganisms that live within us, especially the gut. They’re both friend and foe in fighting cancer.
View all MSK News
2021 Annual Report: Bold Discovery. Life-Changing Care.
MSK medical oncologist Michael Morris, who specializes in treating prostate cancer
A new approach that selectively seeks out and destroys prostate cancer cells represents a major leap forward for treating men with the disease.
Theresa Langley
People of color suffer heartbreaking disparities in cancer outcomes. MSK is determined to help in every facet of cancer care, from lifesaving research to better access to the world’s best treatment.
View the full report
Cancer Straight Talk
Cancer Straight Talk brings together national experts and cancer patients to have straightforward, evidence-based conversations. Medical oncologist Diane Reidy-Lagunes hosts this series with the mission of educating and empowering patients to make the right decisions and live happier, healthier lives.
Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
Upcoming Events
Find a complete list of events at MSK for everyone from patients and caregivers to physicians and researchers.
View all events